Plasma p-tau217 was the strongest individual biomarker for predicting progression to Alzheimer's disease dementia in patients ...
The progression from mild cognitive impairment (MCI) to more severe neurocognitive disorders presents both a clinical challenge and an opportunity for early intervention. Predictive models have ...
Parkinson’s disease is characterised not only by motor impairments but also by a spectrum of cognitive changes that may progress from subtle executive dysfunction to dementia. Early and accurate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results